Dr. Eva Feldman, a neurologist, researcher and director of the A. Alfred Taubman Biomedical Research Institute at the University of Michigan, is the principal investigator for a landmark clinical trial involving patients with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease. The FDA-approved trial, which is currently in the safety phase, involves injecting hundreds of thousands of stem cells into the spinal cords of patients with ALS. As Dr. Feldman explains in this video, it is hoped the stem cells will provide a healthier environment for the patients’ own nerve cells, preserving function and improving quality of life.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?